2020/2021 Microbiology Products Catalog
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Produktkatalog 2015/2016
Produktkatalog 2015/2016 BD Life Sciences Diagnostic Systems Deutschland . Österreich . Schweiz BD stellt sich vor BD Lifeweltweit Sciences – BD – LifeBD MedicalSciences – BD Medical BD – weltweit BD Life Sciences – Biosciences BD Life Sciences – Diagnostic Systems BD, eines der führenden Medizintech- Biosciences bedient den gesamten Diagnostic Systems ist Ihr Experte und nologie-Unternehmen, hat es sich zur Bereich der biologischen und medizi- erfahrener Partner für die klinische Aufgabe gemacht, in Zusammenar- nischen Forschung und bietet die und industrielle mikrobiologische Diag- beit mit seinen Kunden und Partnern größte Auswahl an innovativen Gerä- nostik. den gegenwärtigen und zukünftigen ten und Reagenzien für die zelluläre Umfassende Konzepte und daran ge- Herausforderungen bei der Gesund- Analyse an. knüpfte Diagnostika, Softwarelösun- heitsversorgung von Menschen auf Ein breites Spektrum an Analyzern gen und Dienstleistungen führen zu der ganzen Welt zu begegnen. und Sortern für die Durchflusszyto- gesteigerter Effizienz im Labor und Mit innovativen Lösungen optimiert metrie, verbunden mit kompetenter zu schnelleren verwertbaren Ergeb- BD die Arzneimittelverabreichung, Beratung und Service, ermöglichen nissen. verbessert die Diagnose von Infek- die passgenaue Lösung für Ihr Labor. Unser klinischer Fokus liegt in der Prä- tionskrankheiten und Krebs, unter- Unser Produktangebot und unsere vention und Diagnose von Infektions- stützt die Behandlung von Diabetes Kompetenz machen uns zum interes- krankheiten sowie des Zervixkarzinoms. und bringt die Zellforschung voran. santen Partner für Forschungs- und Für den klinischen Bereich bietet Diag- Rund 30.000 BD-Mitarbeiterinnen Routinelabors, für die Industrie sowie nostic Sytems integrierte Lösungen und Mitarbeiter in 50 Ländern setzen für die wachsende Zahl von bio- und auf den Gebieten Tuberkulose, Sep- sich dafür ein, unser Unternehmens- gentechnologischen Einrichtungen. -
Genomic and Evolutionary Insights
CORE Metadata, citation and similar papers at core.ac.uk Provided by Apollo GBE Preterm Infant-Associated Clostridium tertium, Clostridium cadaveris,andClostridium paraputrificum Strains: Genomic and Evolutionary Insights Raymond Kiu1,2, Shabhonam Caim1, Cristina Alcon-Giner1, Gusztav Belteki3,PaulClarke4, Derek Pickard5, Gordon Dougan5,andLindsayJ.Hall1,* 1The Gut Health and Food Safety Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, United Kingdom 2Norwich Medical School, Norwich Research Park, University of East Anglia, Norwich, United Kingdom 3Neonatal Intensive Care Unit, The Rosie Hospital, Cambridge University Hospitals NHS Foundation Trust, United Kingdom 4Neonatal Intensive Care Unit, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, United Kingdom 5Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom *Corresponding author: E-mail: [email protected]. Accepted: September 28, 2017 Data deposition: This project has been deposited at European Nucleotide Archive (EMBL-EBI) under the accession PRJEB22142. Bacterial strain deposition: Newly sequenced strains are deposited at National Collection of Type Cultures (NCTC; a culture depository of Public Health England). Abstract Clostridium species (particularly Clostridium difficile, Clostridium botulinum, Clostridium tetani and Clostridium perfringens)are associated with a range of human and animal diseases. Several other species including Clostridium tertium, Clostridium cadaveris, and Clostridium paraputrificum have also been linked with sporadic human infections, however there is very limited, or in some cases, no genomic information publicly available. Thus, we isolated one C. tertium strain, one C. cadaveris strain and three C. paraputrificum strains from preterm infants residing within neonatal intensive care units and performed Whole Genome Sequencing (WGS) using Illumina HiSeq. In this report, we announce the open availability of the draft genomes: C. -
OXOID MANUAL PRELIMS 16/6/06 12:18 Pm Page 1
OXOID MANUAL PRELIMS 16/6/06 12:18 pm Page 1 The OXOID MANUAL 9th Edition 2006 Compiled by E. Y. Bridson (substantially revised) (former Technical Director of Oxoid) Price: £50 OXOID MANUAL PRELIMS 16/6/06 12:18 pm Page 2 The OXOID MANUAL 9th Edition 2006 Compiled by E. Y. Bridson (substantially revised) (former Technical Director of Oxoid) 9th Edition 2006 Published by OXOID Limited, Wade Road, Basingstoke, Hampshire RG24 8PW, England Telephone National: 01256 841144 International: +44 1256 841144 Email: [email protected] Facsimile National: 01256 463388 International: +44 1256 463388 Website http://www.oxoid.com OXOID SUBSIDIARIES AROUND THE WORLD AUSTRALIA DENMARK NEW ZEALAND Oxoid Australia Pty Ltd Oxoid A/S Oxoid NZ Ltd 20 Dalgleish Street Lunikvej 28 3 Atlas Place Thebarton, Adelaide DK-2670 Greve, Denmark Mairangi Bay South Australia 5031, Australia Tel: 45 44 97 97 35 Auckland 1333, New Zealand Tel: 618 8238 9000 or Fax: 45 44 97 97 45 Tel: 00 64 9 478 0522 Tel: 1 800 331163 Toll Free Email: [email protected] NORWAY Fax: 618 8238 9060 or FRANCE Oxoid AS Fax: 1 800 007054 Toll Free Oxoid s.a. Nils Hansen vei 2, 3 etg Email: [email protected] 6 Route de Paisy BP13 0667 Oslo BELGIUM 69571 Dardilly Cedex, France PB 6490 Etterstad, 0606 Oxoid N.V./S.A. Tel: 33 4 72 52 33 70 Oslo, Norway Industriepark, 4E Fax: 33 4 78 66 03 76 Tel: 47 23 03 9690 B-9031 Drongen, Belgium Email: [email protected] Fax: 47 23 09 96 99 Tel: 32 9 2811220 Email: [email protected] GERMANY Fax: 32 9 2811223 Oxoid GmbH SPAIN Email: [email protected] Postfach 10 07 53 Oxoid S.A. -
Clostridium Amazonitimonense, Clostridium Me
ORIGINAL ARTICLE Taxonogenomic description of four new Clostridium species isolated from human gut: ‘Clostridium amazonitimonense’, ‘Clostridium merdae’, ‘Clostridium massilidielmoense’ and ‘Clostridium nigeriense’ M. T. Alou1, S. Ndongo1, L. Frégère1, N. Labas1, C. Andrieu1, M. Richez1, C. Couderc1, J.-P. Baudoin1, J. Abrahão2, S. Brah3, A. Diallo1,4, C. Sokhna1,4, N. Cassir1, B. La Scola1, F. Cadoret1 and D. Raoult1,5 1) Aix-Marseille Université, Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes, UM63, CNRS 7278, IRD 198, INSERM 1095, Marseille, France, 2) Laboratório de Vírus, Departamento de Microbiologia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil, 3) Hopital National de Niamey, BP 247, Niamey, Niger, 4) Campus Commun UCAD-IRD of Hann, Route des pères Maristes, Hann Maristes, BP 1386, CP 18524, Dakar, Senegal and 5) Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia Abstract Culturomics investigates microbial diversity of the human microbiome by combining diversified culture conditions, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and 16S rRNA gene identification. The present study allowed identification of four putative new Clostridium sensu stricto species: ‘Clostridium amazonitimonense’ strain LF2T, ‘Clostridium massilidielmoense’ strain MT26T, ‘Clostridium nigeriense’ strain Marseille-P2414T and ‘Clostridium merdae’ strain Marseille-P2953T, which we describe using the concept of taxonogenomics. We describe the main characteristics of each bacterium and present their complete genome sequence and annotation. © 2017 Published by Elsevier Ltd. Keywords: ‘Clostridium amazonitimonense’, ‘Clostridium massilidielmoense’, ‘Clostridium merdae’, ‘Clostridium nigeriense’, culturomics, emerging bacteria, human microbiota, taxonogenomics Original Submission: 18 August 2017; Revised Submission: 9 November 2017; Accepted: 16 November 2017 Article published online: 22 November 2017 intestine [1,4–6]. -
Laboratory Diagnosis of Shigella and Salmonella Infections *
Bull. Org. mond. Sante) 1959, 21, Bull. Wid Hlth Org. 247-277 Laboratory Diagnosis of Shigella and Salmonella Infections * E. HORMAECHE, M.D.' & C. A. PELUFFO, M.D.2 In recent years a great deal of work has been We are aware that experienced bacteriologists devoted to the study of enteric diseases and, in will prefer some of the methods they are using to consequence, many methods have been developed the ones we recommend. This study is not in- for the isolation of their most common agents, tended for them, however, but rather as a guide to Shigella, Salmonella and some pathogenic Esche- people who are just starting work on enteric diseases richia, while at the same time new tests have been diagnosis. For more detailed information, we devised to differentiate the " groups " of the Entero- recommend the books of Kauffmann (1954) and bacteriaceae family, so that the beginner, especially, Edwards & Ewing (1955), of which we have made will be faced with the difficulty of selecting from ample use. among them those to be used. Investigation of enteric pathogens will sometimes Each author has his preferences according to his be the ultimate purpose, as for the public health own experience, and it is regrettable that up to now officer, who is primarily interested in finding them no serious effort has been made to standardize for the potential danger they represent to the com- techniques, which would save a lot of time and dis- munity. In clinical medicine, however, the role couraging failures for the bacteriologist unex- played by the bacteriologist does not end there. -
Medios En Placas Preparadas
Medios de cultivo Hemoderivados, Medios en placas preparadas Sheep Blood in Alsevers Solution Iso-Sensitest Agar (Placa profunda) 25 mL SR0053B 10 x 90 mm PO0779A Iso-Sensitest Agar with Chocolated Horse Blood Sheep Blood Defibrinated 10 x 90 mm PB0147A 25 mL SR0051B Iso-Sensitest Agar with Horse Blood 10 x 90 mm PB0146A Medios en placas preparadas Iso-Sensitest Agar with Horse Blood and 20mg/L NAD 10 x 90 mm PB0378A Agares sangre Iso-Sensitest Agar con sangre de caballo lisada Blood Agar Base No. 2 with Horse Blood 10 x 90 mm PB0145A 10 x 90 mm PB0114A Iso-Sensitest Agar with Sheep Blood Blood Agar Base No. 2 with Sheep Blood 10 x 90 mm PB5003A 10 x 90 mm PB0115A Mueller Hinton Agar Columbia Agar with Horse Blood 10 x 90 mm PO5007A 10 x 90 mm PB0122A Mueller-Hinton Agar with 2% Salt Columbia Agar with Sheep Blood 10 x 90 mm PO0799A^ 10 x 90 mm PB5008A 10 x 90 mm PO5139A+ Columbia Agar with Sheep Blood PLUS Mueller-Hinton Agar 10 x 90 mm PB0123A*^ 10 x 90 mm PO0152A^ 10 x 90 mm PB5039A+ 10x120mm PO1191S Columbia Agar with Chocolated Horse Blood Mueller-Hinton Agar with 5% Sheep Blood 10 x 90 mm PB0124A 10 x 90 mm PB0431A^ 10 x 90 mm PB5007A+ Agares generales para anaerobios Mueller Hinton Agar with Horse Blood Thermo ScientificTM A.R.I.A.TM with Horse Blood 10 x 90 mm PB1229A^ 10 x 90 mm PB1243A 10 x 90 mm PB5303A+ A.R.I.A. -
Clostridium Tertium Isolated from Gas Gangrene Wound; Misidentified As Lactobacillus Spp Initially Due to Aerotolerant Feature
ARTICLE IN PRESS Anaerobe 13 (2007) 161–165 www.elsevier.com/locate/anaerobe Short communication — Anaerobiosis: Molecular Biology, Genetics and Other Aspects Clostridium tertium isolated from gas gangrene wound; misidentified as Lactobacillus spp initially due to aerotolerant feature Shigeki Fujitania,Ã, Chengxu X. Liua, Sydney M. Finegolda, Yuli L. Songa, Glenn E. Mathisenb aInfectious Diseases Section, VA Greater Los Angeles Healthcare System, 11301 Wilshire Blvd., Los Angeles, CA 90073, USA bInfectious Disease Service, UCLA-Olive View Medical Center, 14445 Olive View Dr., Sylmar, CA 91342, USA Received 19 January 2007; received in revised form 24 February 2007; accepted 5 March 2007 Available online 12 March 2007 Abstract Clostridium tertium has been increasingly reported as a human pathogen. This organism is an aerotolerant Gram-positive rod that is often mistaken for other organisms, such as Lactobacillus or Bacillus species. We describe a case of a patient with a history of intravenous drug use presenting to UCLA-Olive View Medical Center with gas gangrene of both upper extremities. The organism was initially misidentified as a Lactobacillus species on aerobic culture plates. However, terminal spore formation was detected in this isolate on a sub- cultured anaerobic culture plate and this isolate was confirmed as C. tertium biochemically and genetically by 16S rDNA sequencing. Additional DNA cloning libraries made from the formalin-fixed specimen revealed Peptoniphilus species and an uncultured Clostridium clone, but not C. tertium. C. tertium might be a causative organism of gas-producing myonecrosis but such an association has never been described. Clinicians should be aware of the phenomenon of aerotolerance of some anaerobes and need to clarify the identification of organisms if the clinical picture does not fit the isolated organism. -
974-Form.Pdf
California Association for Medical Laboratory Technology Distance Learning Program ANAEROBIC BACTERIOLOGY FOR THE CLINICAL LABORATORY by James I. Mangels, MA, CLS, MT(ASCP) Consultant Microbiology Consulting Services Santa Rosa, CA Course Number: DL-974 3.0 CE/Contact Hour Level of Difficulty: Intermediate © California Association for Medical Laboratory Technology. Permission to reprint any part of these materials, other than for credit from CAMLT, must be obtained in writing from the CAMLT Executive Office. CAMLT is approved by the California Department of Health Services as a CA CLS Accrediting Agency (#0021) and this course is is approved by ASCLS for the P.A.C.E. ® Program (#519) 1895 Mowry Ave, Suite 112 Fremont, CA 94538-1766 Phone: 510-792-4441 FAX: 510-792-3045 Notification of Distance Learning Deadline All continuing education units required to renew your license must be earned no later than the expiration date printed on your license. If some of your units are made up of Distance Learning courses, please allow yourself enough time to retake the test in the event you do not pass on the first attempt. CAMLT urges you to earn your CE units early!. CAMLT Distance Learning Course # DL-974 1 © California Association for Medical Laboratory Technology Outline A. Introduction B. What are anaerobic bacteria? Concepts of anaerobic bacteriology C. Why do we need to identify anaerobes? D. Normal indigenous anaerobic flora; the incidence of anaerobes at various body sites E. Anaerobic infections; most common anaerobic infections F. Specimen collection and transport; acceptance and rejection criteria G. Processing of clinical specimens 1. Microscopic examination 2. -
Product List 2008/09
Product List 2008/09 Part of Thermo Fisher Scientific Oxoid Chromogenic Media … Sheer Brilliance™ to reflect this, the names of products are being changed so that the current range now includes: Brilliance Bacillus cereus Agar Brilliance Candida Agar Brilliance E. coli/coliform Agar Brilliance E. coli/coliform Selective Agar Brilliance Enterobacter sakazakii Agar (DFI) Brilliance Listeria Agar Brilliance UTI Agar Brilliance UTI Clarity Agar Brilliance Salmonella Agar The chromogens used in our Brilliance range of chromogenic media ensure that colony colours are vivid, allowing rapid, easy differentiation and presumptive identification of the organism in question. So remember Brilliance – chromogenic media that delivers clearly visible answers on a single culture plate. Contents 1 Culture Media & Supplements 2 Supplementary Reagents 20 Antibiotic Single Supplements 21 Biochemical Reagents 22 Laboratory Preparations & Biological Extracts 22 Veggietones 24 Bagged Media 25 Dip Slides 25 Atmosphere Generation 26 AGS 26 Traditional Systems 27 Food Testing 28 DuPont Qualicon 29 BAX® System, Test and Components 29 Culture Media for the BAX System 30 RiboPrinter® Microbial Characterisation System 31 Lateral Flow System Range 31 Blood Culture 32 Signal 32 Wampole Isolator® 32 Antimicrobial Susceptibility Testing 33 M.I.C.Evaluator Strips 33 aura image 34 AST Accessories 34 Antimicrobial Susceptibility Testing Discs 35 Miscellaneous 38 Sundries 38 Publications 38 Diagnostics 39 Biochemical I.D. 39 Toxin Detection Kits 40 Agglutination Tests 41 Enzyme Immunoassays 42 Immunofluorescence Assays 43 Lateral Flow Assays 44 Environmental Monitoring and Process Simulation 45 Oxoid Air Sampler 45 Environmental Monitoring Swabs 45 Prepared Media 45 Dehydrated Media 45 Process Simulation 46 2 Culture Media and Supplements A wide range of general purpose, enrichment, selective and differential Anaerobe Basal Broth media, diluents and supplements a medium for general growth of anaerobes NB: information provided here is intended only as an aid to purchasing. -
View Our Full Water Sampling Vials Product Offering
TABLE OF CONTENTS Environmental Monitoring 1 Sample Prep and Dilution 8 Dehydrated Culture Media - Criterion™ 12 Prepared Culture Media 14 Chromogenic Media - HardyCHROM™ 18 CompactDry™ 20 Quality Control 24 Membrane Filtration 25 Rapid Tests 26 Lab Supplies/Sample Collection 27 Made in the USA Headquarters Distribution Centers 1430 West McCoy Lane Santa Maria, California Santa Maria, CA 93455 Olympia, Washington 800.266.2222 : phone Salt Lake City, Utah [email protected] Phoenix, Arizona HardyDiagnostics.com Dallas, Texas Springboro, Ohio Hardy Diagnostics has a Quality Lake City, Florida Management System that is certified Albany, New York to ISO 13485 and is a FDA licensed Copyright © 2020 Hardy Diagnostics Raleigh, North Carolina medical device manufacturer. Environmental Monitoring Hardy Diagnostics offers a wide selection of quality products intended to help keep you up to date with regulatory compliance, ensure the efficacy of your cleaning protocol, and properly monitor your environment. 800.266.2222 [email protected] HardyDiagnostics.com 1 Environmental Monitoring Air Sampling TRIO.BAS™ Impact Air Samplers introduced the newest generation of microbial air sampling. These ergonomically designed instruments combine precise air sampling with modern connectivity to help you properly assess the air quality of your laboratory and simplify your process. MONO DUO Each kit includes: Each kit includes: TRIO.BAS™ MONO air sampler, induction TRIO.BAS™ DUO air sampler, battery battery charger and cable, aspirating charger -
How Do Pesticides Influence Gut Microbiota? a Review
International Journal of Environmental Research and Public Health Review Toxicology and Microbiota: How Do Pesticides Influence Gut Microbiota? A Review Federica Giambò 1,†, Michele Teodoro 1,† , Chiara Costa 2,* and Concettina Fenga 1 1 Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Occupational Medicine Section, University of Messina, 98125 Messina, Italy; [email protected] (F.G.); [email protected] (M.T.); [email protected] (C.F.) 2 Clinical and Experimental Medicine Department, University of Messina, 98125 Messina, Italy * Correspondence: [email protected]; Tel.: +39-090-2212052 † Equally contributed. Abstract: In recent years, new targets have been included between the health outcomes induced by pesticide exposure. The gastrointestinal tract is a key physical and biological barrier and it represents a primary site of exposure to toxic agents. Recently, the intestinal microbiota has emerged as a notable factor regulating pesticides’ toxicity. However, the specific mechanisms related to this interaction are not well known. In this review, we discuss the influence of pesticide exposure on the gut microbiota, discussing the factors influencing gut microbial diversity, and we summarize the updated literature. In conclusion, more studies are needed to clarify the host–microbial relationship concerning pesticide exposure and to define new prevention interventions, such as the identification of biomarkers of mucosal barrier function. Keywords: gut microbiota; microbial community; pesticides; occupational exposure; dysbiosis Citation: Giambò, F.; Teodoro, M.; Costa, C.; Fenga, C. Toxicology and Microbiota: How Do Pesticides Influence Gut Microbiota? A Review. 1. Introduction Int. J. Environ. Res. Public Health 2021, 18, 5510. https://doi.org/10.3390/ In recent years, the demand for food has risen significantly in relation to the world ijerph18115510 population’s increase. -
Shigella Dysenteriae Type 1
Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1 World Health Organization TABLE OF CONTENTS i WHO Library Cataloguing-in-Publication Data World Health Organization. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae 1. 1.Dysentery, Bacillary - prevention and control 2.Shigella dysenteriae - pathogenicity 3.Disease outbreaks - prevention and control 4.Guidelines I.Title. ISBN 92 4 159233 0 NLM Classification: WC 282) © World Health Organization 2005 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.